Table 2. Biweekly Feingold Treatment ES for Depressive (Primary Outcome) and Burnout (Secondary Outcome) Symptoms.
Outcome | Assessment time point, ES (95% CI) | |||||
---|---|---|---|---|---|---|
Week 2 | Week 4 | Week 6 | Week 8 | Week 10 | Week 12 | |
Depressive symptoms | −0.10 (−0.21 to 0.01) | −0.19 (−0.37 to −0.002)a | −0.26 (−0.49 to −0.04)a | −0.32 (−0.56 to −0.08)a | −0.37 (−0.62 to −0.13)a | −0.41 (−0.69 to −0.13)a |
Burnout symptoms | ||||||
Cynicism | −0.10 (−0.18 to −0.02)a | −0.19 (−0.31 to −0.04)a | −0.24 (−0.40 to −0.08)a | −0.28 (−0.45 to −0.11)a | −0.31 (−0.49 to −0.14)a | −0.33 (−0.53 to −0.13)a |
Emotional exhaustion | −0.13 (−0.23 to −0.03)a | −0.23 (−0.40 to −0.07)a | −0.31 (−0.51 to −0.11)a | −0.36 (−0.58 to −0.14)a | −0.39 (−0.61 to −0.16)a | −0.39 (−0.64 to −0.14)a |
Professional efficacy | 0.10 (−0.01 to 0.20) | 0.17 (0.005 to 0.34)a | 0.20 (0.005 to 0.40)a | 0.22 (0.01 to 0.43)a | 0.22 (0.001 to 0.43)a | 0.18 (−0.06 to 0.43) |
Abbreviation: ES, effect size.
Designates significant effects (P < .05).